The Journal of Bone and Joint Surgery (American) 83:S163-163 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.
Thoughts on Clinical Trials to Evaluate the Action and Effectiveness of BMPs in Bone Healing
Michael W. Chapman, MD
University of California at Davis, Department of Orthopaedic
Surgery, 4860 Y Street, Suite 3800, Sacramento, CA 95817
The author did not receive grants or outside funding in support
of his research or preparation of this manuscript. He did not receive
payments or other benefits or a commitment or agreement to provide
such benefits from a commercial entity. No commercial entity paid
or directed, or agreed to pay or direct, any benefits to any research
fund, foundation, educational institution, or other charitable or
nonprofit organization with which the author is affiliated or associated.
| The first 150 words of the full text of this article appear below. |
Bone morphogenetic proteins (BMPs) have a number of potential
applications in bone healing and in the treatment of other bone
disorders. Potential applications include the following:
accelerating normal bone healing
increasing the prevalence of the union of fractures and potentially increasing
the strength of the callus formed in initial fracture healing
increasing the effectiveness of autologous or allogeneic bone grafting
to improve fracture healing, heal bone defects, or treat nonunions
accelerating the rate of consolidation and increasing the prevalence
of union in distraction osteogenesis
replacing autogenous bone graft in treating deficiencies in bone union
to eliminate the cost and morbidity of harvesting autologous bone
increasing the rate of consolidation and strength of bone union in
reconstructive procedures such as spine arthrodesis and other arthrodeses
inducing bone formation in pathological bone defects
increasing bone mass disorders such as postmenopausal and disuse
osteoporosis
In clinical trials of BMPs, investigators thus far have . . . [Full Text of this Article]

CiteULike Connotea Del.icio.us Technorati What's this?
|